statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Needham  Company LLC reaffirmed their buy rating on shares of Liquidia (NASDAQ:LQDA - Free Report) in a report released on Monday morning, Benzinga reports. Needham  Company LLC currently...

Needham & Company LLC Reiterates Buy Rating for Liquidia (NASDAQ:LQDA)

Liquidia (NASDAQ:LQDA - Get Free Report)s stock had its "buy" rating reissued by equities research analysts at Needham  Company LLC in a research report issued on Monday, Benzinga...

Liquidia (NASDAQ:LQDA) Given "Buy" Rating at Needham & Company LLC

MORRISVILLE, N.C., April 02, 2024 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) (Liquidia or the Company) announced today that Dr. Roger Jeffs, Chief Executive Officer, and Micheal...

Liquidia Corporation to Present at 23rd Annual Needham Virtual Healthcare Conference

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Liquidia provides YUTREPIA regulatory update

On March 28, Judge Andrews removed the injunction issued in the Original Hatch Waxman LitigationOn March 29, Judge Bates denied United Therapeutics' motion for temporary restraining order and...

Update on Favorable Legal and Regulatory Outcomes Clearing Path for Potential FDA approval of YUTREPIA  (treprostinil) inhalation powder

United Therapeutics motion for restraining order over Liquidia's Yutrepia denied...

United Therapeutics motion for restraining order over Liquidia's Yutrepia denied

This indicator may be signaling that LQDA's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...

Liquidia (LQDA, $14.72) entered Downtrend as Momentum indicator drops below 0 level on Mar 28, 2024

This is a Bearish indicator signaling LQDA's price could decline from here. Traders may explore shorting the stock or put options...

Liquidia (LQDA, $14.72) Moving Average Convergence Divergence (MACD) Histogram turned negative on March 28, 2024

Liquidia gains after court win in patent dispute with United Therapeutics...

Liquidia gains after court win in patent dispute with United Therapeutics

Liquidia Corp. operates as a holding company which through its subsidiary engages in developing and commercializing biopharmaceutical products. It engages in novel products development used in PRINT technology to transform the lives of patients. The company was founded on June 28, 2020, and is headquartered in Morrisville, NC.

Volume	30.00
52-Wk High	$16.99
52-Wk Low	$5.71

LQDA Liquidia Corp

About

Feed

News

Sentiment

Earnings

Fundamentals

Sentiment

Message Volume

Community